Matthew Rosenberg serves as Executive at NEPHROS INC, where they oversee executive responsibilities. Since joining the company, Matthew Rosenberg has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 9, 2015 involved receiving (via award) 58,240 shares valued at $0.
Matthew Rosenberg currently holds 847,935 shares of NEPHROS INC (NEPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Rosenberg has been a net neutral trader of NEPH stock. They have purchased $0 and sold $0 worth of shares.
Matthew Rosenberg's most recent insider trade was on Sep 9, 2015, when they sold 58,240 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 18, 2014 | NEPH | $225.0K | Other | 374,997 | $0.60 | Discretionary |
| Nov 6, 2014 | NEPH | $0 | Award | 12,698 | $N/A | Discretionary |